Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Profound MedicalPROF +1.47%69 Days Sales Outstanding is 142.11 as of Mar. 2026, which is 33% below its 10-year median of 212.27. GuruFocus rates PROF with a GF Score™ of 69/100 and a GF Value™ of $14.75 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 810 Medical Devices & Instruments companies, Profound Medical ranks worse than 86.42% on this metric.
The historical rank and industry rank for Profound Medical's Days Sales Outstanding or its related term are showing as below:
PROF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 129.23 Med: 212.27 Max: 412.12
Current: 129.23
During the past 12 years, Profound Medical's highest Days Sales Outstanding was 412.12. The lowest was 129.23. And the median was 212.27.
PROF's Days Sales Outstanding is ranked worse than 86.42% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.85
vs PROF: 129.23
Profound Medical's Days Sales Outstanding
declined
from Mar. 2025 (198.74) to Mar. 2026 (142.11).
Profound Medical (NAS:PROF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Profound Medical Days Sales Outstanding Related Terms
Profound Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Profound Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PROF vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Profound Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profound Medical Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Profound Medical's Days Sales Outstanding falls into.
Profound Medical Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 142.11 mean?
Profound Medical (PROF) has a Days Sales Outstanding of 142.11 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Profound Medical and its competitors. This is 33% below median its historical median of 212.27. Over the past decade, Profound Medical's Days Sales Outstanding has ranged from 129.23 to 412.12. According to the industry distribution chart, Profound Medical ranks #700 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 86.4%.
Is Profound Medical's Days Sales Outstanding too high?
Profound Medical's current Days Sales Outstanding of 142.11 is 33% below median its 10-year median of 212.27. Over the past 10 years, this metric has ranged from a low of 129.23 to a high of 412.12. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.85. Profound Medical's value of 142.11 is 115.8% above this industry median. Based on the distribution chart, Profound Medical ranks #700 out of 810 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Profound Medical has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Profound Medical ranks #700 out of 810 companies for Days Sales Outstanding. This places Profound Medical in the lower half of its industry. The industry median Days Sales Outstanding is 65.85. Profound Medical's value of 142.11 is 115.8% above this benchmark. Historically, Profound Medical's own Days Sales Outstanding has ranged from 129.23 to 412.12 over the past decade. While the company's 10-year median is 212.27 vs. the industry median of 65.85, Profound Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.85, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profound Medical's current Days Sales Outstanding of 142.11 is 115.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Profound Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profound Medical's current Days Sales Outstanding is 142.11, which is 33% below median its own 10-year median of 212.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (PROF) is currently considered Possible Value Trap. The stock's GF Value™ is $14.75, compared to a current price of $6.91 — trading 53.2% below its estimated fair value. The current Days Sales Outstanding is 142.11, which is 33% below median its 10-year median of 212.27 and 115.8% above the Medical Devices & Instruments industry median of 65.85. Profound Medical's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Profound Medical (PROF), the current Days Sales Outstanding is 142.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profound Medical (PROF) Overvalued in 2026?
Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued.
The current stock price of $6.91 is trading 53.2% below its estimated GF Value™ of $14.75.
GuruFocus considers Profound Medical to be Possible Value Trap.
Key valuation signals for PROF:
Days Sales Outstanding: 142.11 (33% below median its 10-year median of 212.27)
GF Value™: $14.75 vs. price of $6.91 (53.2% below fair value)
Industry Position: 115.8% above the Medical Devices & Instruments median (#700 of 810)
No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
69GF Score
Get the complete analysis for PROF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PROF has been successfully added to your 
